osimertinib
astrazeneca
['adaura', 'osimertinib', 'aura ,(-laura)']
adaura trial. impressive overall survival benefit for adjuvant osimertinib hr:0.49 #asco2023 
Thoracic Oncologist - Head of Thoracic Group, Department of Medical Oncology - Institut Gustave Roussy (IGR) - Villejuif - France 🇫🇷 and CICT member